D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 57 Citations 16,309 194 World Ranking 1625 National Ranking 786

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Alzheimer's disease

His primary scientific interests are in Pathology, Alzheimer's disease, Internal medicine, Dementia and Frontotemporal dementia. His Pathology research focuses on C9orf72 and Amyotrophic lateral sclerosis. His studies deal with areas such as Biomarker, Positron emission tomography, Nuclear medicine and Amyloid as well as Alzheimer's disease.

His studies in Positron emission tomography integrate themes in fields like Concordance, Neuroimaging and Medical imaging. His Internal medicine research incorporates themes from Differential diagnosis and Oncology. His Frontotemporal dementia study incorporates themes from Genetics and Apolipoprotein E.

His most cited work include:

  • Classification of primary progressive aphasia and its variants (2532 citations)
  • Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 (1147 citations)
  • Functional anatomy of a common semantic system for words and pictures (1034 citations)

What are the main themes of his work throughout his whole career to date?

Neuroscience, Pathology, Disease, Internal medicine and Frontotemporal dementia are his primary areas of study. His Pathology study is mostly concerned with Amyloid and Alzheimer's disease. The study incorporates disciplines such as Neurology, Cerebrospinal fluid and Bioinformatics in addition to Disease.

The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology. His Frontotemporal dementia research is multidisciplinary, relying on both Genetics and Atrophy. His biological study spans a wide range of topics, including Apolipoprotein E and Cognition.

He most often published in these fields:

  • Neuroscience (21.71%)
  • Pathology (22.48%)
  • Disease (19.24%)

What were the highlights of his more recent work (between 2019-2021)?

  • Frontotemporal dementia (18.10%)
  • Disease (19.24%)
  • Internal medicine (20.76%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Frontotemporal dementia, Disease, Internal medicine, Pathology and C9orf72. His Frontotemporal dementia study introduces a deeper knowledge of Dementia. His Dementia research includes themes of Genotype and Biomarker discovery.

His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology. His Tauopathy, Neuropathology and Frontotemporal lobar degeneration study in the realm of Pathology interacts with subjects such as Amyloid pathology. The Frontotemporal lobar degeneration study combines topics in areas such as Neurofibrillary tangle and Amyotrophic lateral sclerosis.

Between 2019 and 2021, his most popular works were:

  • Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. (43 citations)
  • Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders (21 citations)
  • Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. (18 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cognition

His primary areas of study are Frontotemporal dementia, Dementia, Internal medicine, Disease and C9orf72. His work carried out in the field of Frontotemporal dementia brings together such families of science as Pathological, Cohort study, Apathy, Pediatrics and Atrophy. His research integrates issues of Apolipoprotein E, Biomarker discovery and Amyloid in his study of Dementia.

His Internal medicine research incorporates elements of Gastroenterology, Oncology and Cardiology. His C9orf72 study combines topics from a wide range of disciplines, such as Biomarker and Frontotemporal lobar degeneration. In his work, Pathology is strongly intertwined with Hippocampal formation, which is a subfield of Frontotemporal lobar degeneration.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Classification of primary progressive aphasia and its variants

M L Gorno-Tempini;M L Gorno-Tempini;A E Hillis;S Weintraub;A Kertesz.
Neurology (2011)

3337 Citations

Functional anatomy of a common semantic system for words and pictures

R. Vandenberghe;C. Price;R. Wise;O. Josephs.
Nature (1996)

1403 Citations

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

Marc Cruts;Ilse Gijselinck;Julie van der Zee;Sebastiaan Engelborghs.
Nature (2006)

1354 Citations

A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study

Ilse Gijselinck;Tim Van Langenhove;Julie van der Zee;Kristel Sleegers.
Lancet Neurology (2012)

761 Citations

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment : a phase 2 trial.

Rik Vandenberghe;Rik Vandenberghe;Koen Van Laere;Adrian Ivanoiu;Eric Salmon.
Annals of Neurology (2010)

608 Citations

The neural systems sustaining face and proper-name processing.

M L Gorno-Tempini;C J Price;O Josephs;Rik Vandenberghe.
Brain (1998)

601 Citations

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

Michael F. Egan;James Kost;Pierre N. Tariot;Paul S. Aisen.
The New England Journal of Medicine (2018)

412 Citations

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
JAMA (2015)

405 Citations

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez.
Nature Genetics (2017)

382 Citations

The Response of Left Temporal Cortex to Sentences

R. Vandenberghe;A. C. Nobre;C. J. Price.
Journal of Cognitive Neuroscience (2002)

382 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Rik Vandenberghe

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 313

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 294

John R. Hodges

John R. Hodges

University of Sydney

Publications: 274

Bruce L. Miller

Bruce L. Miller

University of California, San Francisco

Publications: 266

Olivier Piguet

Olivier Piguet

University of Sydney

Publications: 212

Gil D. Rabinovici

Gil D. Rabinovici

University of California, San Francisco

Publications: 150

Keith A. Josephs

Keith A. Josephs

Mayo Clinic

Publications: 149

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 136

Rosa Rademakers

Rosa Rademakers

Mayo Clinic

Publications: 135

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 135

Maria Luisa Gorno-Tempini

Maria Luisa Gorno-Tempini

University of California, San Francisco

Publications: 134

Murray Grossman

Murray Grossman

University of Pennsylvania

Publications: 129

Jonathan D. Rohrer

Jonathan D. Rohrer

University College London

Publications: 124

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 123

Victor L. Villemagne

Victor L. Villemagne

University of Pittsburgh

Publications: 119

Christian Haass

Christian Haass

Ludwig Maximilian University of Munich

Publications: 119

Something went wrong. Please try again later.